1. Home
  2. SBSI vs DBVT Comparison

SBSI vs DBVT Comparison

Compare SBSI & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southside Bancshares Inc.

SBSI

Southside Bancshares Inc.

HOLD

Current Price

$31.72

Market Cap

950.3M

Sector

Finance

ML Signal

HOLD

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

HOLD

Current Price

$9.75

Market Cap

850.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSI
DBVT
Founded
1960
2002
Country
United States
France
Employees
N/A
90
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
950.3M
850.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SBSI
DBVT
Price
$31.72
$9.75
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$34.00
★ $38.55
AVG Volume (30 Days)
115.2K
★ 359.2K
Earning Date
10-29-2026
10-28-2026
Dividend Yield
★ 4.68%
N/A
EPS Growth
N/A
★ 10.26
EPS
★ 1.68
N/A
Revenue
N/A
★ $5,636,000.00
Revenue This Year
$4.65
N/A
Revenue Next Year
$3.15
$1,630.16
P/E Ratio
$18.86
★ N/A
Revenue Growth
N/A
★ 35.77
52 Week Low
$27.59
$8.63
52 Week High
$36.20
$26.19

Technical Indicators

Market Signals
Indicator
SBSI
DBVT
Relative Strength Index (RSI) 61.73 39.04
Support Level $31.69 $8.63
Resistance Level $33.34 $12.73
Average True Range (ATR) 0.54 0.44
MACD 0.21 0.13
Stochastic Oscillator 94.78 52.71

Price Performance

Historical Comparison
SBSI
DBVT

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: